Companies/US/ANVS

ANNOVIS BIO, INC.

Last · —$1.02-0.04 (-3.77%)live · yahoo · 1h ago
Vol 844.2K ≈ 861.1K
Market cap$43.53M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session

Issuer

Legal nameANNOVIS BIO, INC.
HQUnited States (US)
ListingUS ANVS
ISINUS03615A1088
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC2834
CurrencyUSD
Entity registrysec:0001477845
CIK0001477845
LinkedIn
Employees7
AddressAnnovis Bio, Inc. 101 Lindenwood Drive 19355, Malvern +484 875 3192
Loading chart…

OpenFilings analyst

Our analyst

10-K · 2026-03-13

From latest 10-K · 2026-03-13

  • Operating Cf Burn
  • Cash Runway Low
  • Accumulated Deficit High

Red flags

  • Operating Cf Burn — Negative operating cash flow
  • Cash Runway Low — Cash runway ~0.8 years
  • Accumulated Deficit High — Accumulated deficit / equity 971%

Press & signals

3 recent
  • GlobeNewswire

    Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results

  • Satelight

    Annovis Announces Partnership with Weave Bio, AI Regulatory Platform, in

  • Satelight

    Annovis Provides Corporate Updates and Second Quarter 2026 Financial

Documents

FormReporting forFiledFlags
2026-06-302026-08-14 2
2026-07-072026-07-100
2026-05-202026-05-210